Jane Street’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-13,182
Closed -$10.9K 10608
2022
Q4
$10.9K Buy
+13,182
New +$14.7K ﹤0.01% 8752
2022
Q1
Sell
-1,442
Closed -$10K 11430
2021
Q4
$10K Buy
+1,442
New +$16.5K ﹤0.01% 9910
2020
Q1
Sell
-60
Closed -$5K 6241
2019
Q4
$5K Buy
+60
New +$4.21K ﹤0.01% 4970
2018
Q3
Sell
-166
Closed -$142K 5919
2018
Q2
$142K Buy
+166
New +$138K ﹤0.01% 4673
2014
Q4
Sell
-66
Closed -$80K 3189
2014
Q3
$80K Sell
66
-402
-86% -$578K ﹤0.01% 2385
2014
Q2
$853K Buy
+468
New +$625K 0.01% 1015

Other funds holding HSTO

Jane Street's HSTO Position: Q1 2023 in Review

Jane Street sold out of Histogen Inc. Common Stock (HSTO) in Q1 2023, closing a stake of 13,182 shares — an estimated $10.9K sold.

Jane Street first reported a position in HSTO in Q2 2014 and held it in 6 quarters. The position peaked at $853K in Q2 2014. 14 funds tracked by Wall St. Rank hold HSTO as of Q1 2023.

  • Jane Street reported no remaining Histogen Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Jane Street sold 13,182 Histogen Inc. Common Stock shares in Q1 2023, an estimated $10.9K.
  • Jane Street first reported a position in Histogen Inc. Common Stock in Q2 2014 and held it in 6 quarters.
  • Jane Street's Histogen Inc. Common Stock position peaked at $853K in Q2 2014.
  • 14 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.